Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
556
-
Total 13F shares, excl. options
-
52,969,373
-
Shares change
-
+13,898
-
Total reported value, excl. options
-
$7,965,191,033
-
Value change
-
-$132,450,866
-
Put/Call ratio
-
116%
-
Number of buys
-
248
-
Number of sells
-
370
-
Price
-
$150.52
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2025
As of 31 Mar 2025 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) had 556 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,969,373 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., UBS Group AG, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, STATE STREET CORP, Allspring Global Investments Holdings, LLC, GEODE CAPITAL MANAGEMENT, LLC, Impactive Capital LP, and Invesco Ltd..
This table shows 557 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.